MEA Case Report

MEA, Diagnosed approximately 18 months prior to treatment with PKD. Subject recently placed on hospice due to continuous progression of symptoms. Case Study Data suggests immediate and persistent remediation of symptoms has improved of quality of life.

Aggregate discomfort due to tremor and other symptoms from a pre-treatment distress score of 26 to a post treatment distress score of 2, immediately following treatment.

Subject reported quality durable quality of life improvements with approximately three-fold decrease in symptom related distress from 26 to 8.

PEMF Symptom reduction in PKD

	Initial with Palliative	5 min Post PEMF	7 Days Post PEMF + ePad	Post 2nd PEMF	Day 14 Ongoing
Head Bob Travel	6-8"	2"	3"	1"	1"
Head Bob Presence	100%	20%	30%	10%	<10%
Leg Shake Travel	1-2"	0	0	0	0
Leg Shake Presence	100%	5%	10%	<10%	<10%
Hand Shake Travel	1-2"	0	.5"	0	.5"
Hand Shake Presence	100%	0	15%	0	<5%
Normal Gait Steps	0			3	3
Neck Back Pain 1-10	7	1	5	1	3
Physchological Distress 1-10	10	1	3	1	2
Sleep Inhibition 1-10	9	3	4	3	3
Total Distress	26	2	11	5	8

 

Key

Therapy	Symptom Description
PEMF Therapy included: 6 minutes of butterfly occipital lobes in horizontal position around ears 6 minutes of butterfly probe and vertical positions top and back of head 6 minutes zeta probe occipital area 6 minutes small loop on low back 6 minutes zeta probe on neck sore areas.	Head Bob Travel - The approximate distance the forehead travelled at each involuntary spasm Head Bob Presence - The approximate percentage of time Head Bob present during evaluation.
ePad Therapy from history of brain swelling: 6x8" ePad on top & back of head During sleep in nightcap 3.0 mR/h output.	Leg Shake Travel - The approximate distance both knees moved due to involuntary ankle motion. Leg Shake Presence - Approximate percentage of time legs exhibited involuntary movement
Ongoing Therapy PEMF Suspended / Equipment not available ePad continued	Hand Shake Travel - The approximate distance both thumbs moved on each oscillation due to involuntary arm motion. Hand Shake Presence - The approximate percentage of time hands exhibited visible involuntary motion.
Subjective Evaluation Keys: Subject reported "I feel bad" Subject reported "I Feel bood" Subject reported "I feel pretty good"	Normal Gait Steps - the number of steps before shuffling starts. Neck/Back Pain - Unresolved discomfort in neck and back.
Total Distress - Sum of all numeric guages of discomfort relating to symptoms and sources of discomfort. Decreased value during therapy indicates improved quality of life.	Phychological Distress - subjects expression of compromised of quality of life due to symptoms. Sleep Inhibition - Reported absence of quality of sleep.

For More information on PEMF or contact Whole Health Network.

PEMF Parkinsons

There are a growing number of references using PEMF, Pulsed Electromagnetic Field, therapy for control of Parkinson's related symptoms. Live PubMed Search
We conducted a confirmation experiment using MagnaPulse PEMF device to determine if this device performed consistently with published data.
After obtaining informed consent, the individual in this video exposed himself to 15 minutes of PEMF on the head. In this case the therapeutic response was immediate, tremors substantially resolved within 15 minutes, and remained minor for 4 days in conjunction with pharmaceutical use. On a repeated exposure, the subject elected to repeat the experiment without pharmaceuticals, and the tremor reduction response persisted for 3 days.
There were no adverse effects. Subject reported improved calm and sense of well being.

More PEMF, Parkinson's Therapy and Health Solutions at these links.
Please add your own experience to this posting:

• How complete was your relief?
• What was your before-therapy tremor level from 1-10?
• What was your after-therapy tremor level from 1-10?
• What was your before-therapy nervous-jitter level from 1-10?
• What was your after-therapy nervous-jitter level from 1-10?
• How many days did your relief last?
• If you sensed a durable reduction in symptoms, how much was it?
• How long have you had the condition?
• What other therapies have you tried?